Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recent Financing Allows WellGen to Begin Studies - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Recent Financing Allows WellGen to Begin Studies

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Recent Financing Allows WellGen to Begin Studies
WellGen, Inc., New Brunswick, NJ, has completed its Series B financing totaling $3 million. The capital raised from this latest round of financing will provide the company with the additional resources it needs to begin clinical studies in humans under its Obesity and Inflammation Programs, which are aimed at developing and bringing to market a variety of new and promising nutritional products. Investors in this round of financing include both new and existing WellGen shareholders.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics